We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

16 Nov 2026 - 19 Nov 2026
08 Dec 2026 - 10 Dec 2026

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

By HospiMedica International staff writers
Posted on 08 Oct 2026

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. More...

For automated insulin delivery, a key challenge is maintaining accurate glucose measurements when insulin is delivered near the sensor. A new investigational wearable patch is now being evaluated to combine continuous glucose monitoring, insulin delivery, and automated glucose control in one device.

The device, niia signature, is an investigational wearable patch jointly developed by PharmaSens and SiBionics following their collaboration announced in June 2025. It is designed to combine continuous glucose monitoring, insulin delivery, and an automated glucose control algorithm in a single wearable system, with the goal of reducing the burden of managing separate devices for automated insulin delivery.

At the 2026 Annual Meeting of the European Association for the Study of Diabetes (EASD 2026), SiBionics presented its “See More, Act Earlier” concept through three exhibition chapters linking continuous sensing with future diabetes care. The concept was further explored during the SiBionics industry symposium, “From Sensors to Integrated Care: Emerging Technologies Shaping the Future of Diabetes Management,” where researchers presented initial findings from the SMART02 feasibility study evaluating an early prototype of niia signature.

The study examined whether glucose measurement performance could be maintained when insulin was delivered close to the sensor. In the second part of the study, the prototype was also evaluated together with the automated glucose control algorithm, providing an early assessment of the integrated system.

Temporary interference following a bolus was uncommon overall and occurred mainly with doses of 10 units or more, where the probability ranged from 20% to 25%. When interference occurred, the sensor signal fully recovered on average within approximately 20 minutes after bolus delivery. The PharmaSens niia patch pump, SiBionics sensor, and automated glucose control algorithm otherwise performed consistently throughout the study.

The findings represent an early development milestone for the integrated system, although further research is needed to confirm its performance, evaluate longer-term use, and determine its potential clinical role. niia signature remains investigational, has not been approved or cleared in any market, and is not available for sale.

Related Links
SiBionics
PharmaSens


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Monitor/Defibrillator
Zenix
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.